Target intelligence / Profile preview

RNA, U6 small nuclear 30, pseudogene (RNU6-30P)

Target
RNU6-30P
Molecular classification
Pseudogene, Small nuclear RNA pseudogene
01

Overview

RNU6-30P is a member of the U6 small nuclear RNA pseudogene family. The functional U6 small nuclear RNA (snRNA) is a highly conserved noncoding RNA involved in the spliceosome and pre-mRNA splicing in eukaryotic cells[1][3][6]. However, RNU6-30P, by definition as a pseudogene, does not produce a functional RNA molecule and does not contribute to cellular processes. Pseudogenes arise by duplication or retrotransposition of functional genes but acquire disabling mutations, rendering them nonfunctional[7]. They are typically not transcribed or, if transcribed, do not produce products with biological activity. Key context: - Functional U6 small nuclear RNA (not the pseudogene) is essential for the spliceosome, the complex responsible for pre-mRNA splicing[1][2][6]. Mutations and modifications of U6 snRNA can impact splicing efficiency but there is no evidence that the RNU6-30P pseudogene is expressed or acts in this capacity[7]. - Pseudogenes, including RNU6-30P, are generally not involved in disease, do not act as drug targets, and have no known role as biomarkers. Summary: RNU6-30P is a nonfunctional RNA pseudogene, not a tissue-expressed RNA, enzyme, receptor, or other molecular target relevant to therapeutics or diagnostics. No drugs, biomarkers, or clinical considerations exist for this pseudogene.

Other names
RNU6-30RNU6-30P

Beyond the preview

Go deeper on RNA, U6 small nuclear 30, pseudogene (RNU6-30P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 30, pseudogene (RNU6-30P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call